UCB - Selling And Administration Expenses

Stock Price
270.40
Daily Change
-5.70 -2.06%
Monthly
4.40%
Yearly
48.49%
Q1 Forecast
269.39

UCB reported EUR1.29B in Selling and Administration Expenses for its fiscal semester ending in December of 2024.





Selling And Administration Expenses Change Date
Alcon AG USD 865M 5M Sep/2025
Amarin USD 17.94M 17.86M Sep/2025
argenx SE USD 336.29M 14.94M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Galapagos EUR 34.55M 3.88M Sep/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Orion EUR 110.7M 26.1M Dec/2025
Recordati EUR 171.38M 15.6M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
UCB EUR 1.29B 221M Dec/2024
Unibail Rodamco EUR 90M 6.4M Jun/2025